BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12759562)

  • 1. Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference.
    Franchimont D; Kino T; Galon J; Meduri GU; Chrousos G
    Neuroimmunomodulation; 2002-2003; 10(5):247-60. PubMed ID: 12759562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.
    Franchimont D
    Ann N Y Acad Sci; 2004 Jun; 1024():124-37. PubMed ID: 15265777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the role of glucocorticoids in inflammation.
    Ronchetti S; Migliorati G; Bruscoli S; Riccardi C
    Clin Sci (Lond); 2018 Jul; 132(14):1529-1543. PubMed ID: 30065045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor in human respiratory epithelial cells.
    Pujolsa L; Mullol J; Picado C
    Neuroimmunomodulation; 2009; 16(5):290-9. PubMed ID: 19571590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
    Barnes PJ
    Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
    Hapgood JP; Avenant C; Moliki JM
    Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting inflammation using selective glucocorticoid receptor modulators.
    De Bosscher K; Haegeman G; Elewaut D
    Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cells present an innate resistance to glucocorticoid treatment: implications for therapy of primary vasculitis.
    Koenen P; Barczyk K; Wolf M; Roth J; Viemann D
    Ann Rheum Dis; 2012 May; 71(5):729-36. PubMed ID: 22203687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and resistance in glucocorticoid control of inflammation.
    Barnes PJ
    J Steroid Biochem Mol Biol; 2010 May; 120(2-3):76-85. PubMed ID: 20188830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
    Ingawale DK; Mandlik SK; Patel SS
    J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucocorticoid receptor in inflammatory processes: transrepression is not enough.
    Hübner S; Dejager L; Libert C; Tuckermann JP
    Biol Chem; 2015 Nov; 396(11):1223-31. PubMed ID: 25910399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
    Goulding NJ
    Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory glucocorticoids: changing concepts.
    Newton R
    Eur J Pharmacol; 2014 Feb; 724():231-6. PubMed ID: 23747654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of action of glucocorticoids].
    Dejean C; Richard D
    Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.